Congenital Heart Disease
527
78
93
260
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
43 trials with published results (8%)
Research Maturity
260 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.5%
34 terminated out of 527 trials
88.4%
+1.9% vs benchmark
4%
19 trials in Phase 3/4
17%
43 of 260 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 260 completed trials
Clinical Trials (527)
Longitudinal Validation of CIRC Technologies
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
The Genetic Basis of Congenital Heart Disease in Africa
Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit
Observational Data Collection for Blood Hemoglobin Algorithm Validation in Pediatrics
Learning by Heart: The Effectiveness of an EF Training Program for Pre-schoolers With a Severe CHD
Exercise Prehabilitation in Congenital Heart Disease
Screening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolescents With Increased Cardiovascular Risk Due to Chronic Diseases Such as Congenital Heart Disease, Chronic Inflammatory Bowel Disease, Celiac Disease and Rheumatic Disorders
Autus Valve Pivotal Study
Autus Valve Continued Access Study (CAS)
Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires
Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease
Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation
HFNC vs NIPPV Following Extubation
Characterizing the Effect of Dopamine on Markers of Lymph Re-circulation in Fontan-associated Protein-losing Enteropathy
Interoceptive Intervention for Congenital Heart Disease
An Observational Study to Learn More About How Safe Rivaroxaban is And How Well it Works in Children With Congenital Heart Disease Who Had a Heart Surgery Called the Fontan Procedure
Neuro-cardiac Rehabilitation in Youth With Congenital Heart Disease (QUALINEUROREHAB)
Application of Ultrasound Technique in Locating the End of the Gastric Tube in Children Aged 0-6 Years